Chemkart India Limited submitted an investor presentation to BSE showcasing its position as a B2B supplier of raw ingredients for nutritional, sports, and health supplements. The company, established in 2015 and headquartered in Mumbai, reported strong financial performance with revenue growing from ₹131.38 crores in FY23 to ₹203.28 crores in FY25, representing a 32.7% three-year CAGR. EBITDA increased with a 67.1% CAGR and PAT showed 64.2% CAGR over the same period. The company operates with over 150 ingredients across 10+ product categories, serving 500+ clients with a 30,000 sq.ft warehouse facility in Bhiwandi. Chemkart announced construction of a greenfield nutraceutical CDMO facility through its subsidiary Easy Raw Materials at JNPT SEZ, Maharashtra, expected to be operational by FY27. The facility will focus on manufacturing, packaging, and export of health supplements with technologies like microencapsulation and liposomal delivery systems. The company maintains domestic revenue at 99.25% with minimal export presence currently.
Chemkart India Limited announced that its wholly owned subsidiary Easy Raw Materials Pvt. Ltd. (EZRM) has commenced construction of a greenfield nutraceutical manufacturing facility at JNPA Special Economic Zone in Maharashtra. The facility will operate as a Contract Development and Manufacturing Organization (CDMO) focusing on formulation, packaging, and global exports of health supplements. The project represents Chemkart's strategic expansion from trading and distribution into manufacturing. The facility is being built on a 4,120 sq.m plot leased for 60 years and will incorporate advanced technologies including microencapsulation and liposomal delivery systems. Construction milestones include completed site clearance, ongoing platform excavation, and initiated pile foundation work. The SEZ location provides duty-free import-export benefits and proximity to India's largest container port for enhanced global market access.